|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 26.3 EUR | -0.31% |
|
-0.84% | -21.41% |
| 28/06 | Borse Frankfurt-News: Uncertainty ahead of French election (Bond Trading) | DP |
| 27/06 | Chemicals collective agreement: Bonus days for union members | DP |
FRANKFURT (Reuters) - Agriculture and pharmaceuticals company Bayer on Tuesday reported higher adjusted quarterly earnings on strong demand for its seeds and pesticides and it confirmed its full-year guidance.
Bayer said in a statement that third-quarter adjusted EBITDA gained 17.3% to 2.45 billion euros ($2.45 billion), above an average analyst estimate of 2.31 billion euros posted on the company's website.
Bayer, which has been hit by litigation costs over claims that a weedkiller it acquired under its Monsanto takeover causes cancer, confirmed its full-year outlook.
(Reporting by Ludwig Burger, editing by Kirsti Knolle)
| 1st Jan change | Capi. | |
|---|---|---|
| -21.41% | 2.78TCr | |
| +55.73% | 82TCr | |
| +43.33% | 64TCr | |
| -5.48% | 35TCr | |
| +17.75% | 31TCr | |
| +11.63% | 30TCr | |
| +16.72% | 24TCr | |
| +2.54% | 22TCr | |
| +14.21% | 22TCr | |
| +9.88% | 17TCr |
BAYER AG 
